APL Healthcare Limited — Tenofovir Exporter Profile
Indian Pharmaceutical Exporter · #8 for Tenofovir · $2.6M export value · DGFT Verified
APL Healthcare Limited is the #8 Indian exporter of Tenofovir with $2.6M in export value and 53 verified shipments. APL Healthcare Limited holds a 0.1% market share in Tenofovir exports across 10 countries. The company exports 17 pharmaceutical products worth $27.3M across 11 therapeutic categories.
APL Healthcare Limited — Tenofovir Export Profile: Buyers & Destinations
Where Does APL Healthcare Limited Export Tenofovir?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TANZANIA | $1.1M | 23 | 44.3% |
| MYANMAR | $550.0K | 11 | 21.2% |
| NIGERIA | $300.0K | 6 | 11.6% |
| SOUTH AFRICA | $200.0K | 4 | 7.7% |
| MOZAMBIQUE | $150.0K | 3 | 5.8% |
| NEPAL | $50.0K | 1 | 1.9% |
| TOGO | $50.0K | 1 | 1.9% |
| BURKINA FASO | $50.0K | 1 | 1.9% |
| CONGO | $50.0K | 1 | 1.9% |
| MALTA | $44.3K | 2 | 1.7% |
APL Healthcare Limited exports Tenofovir to 10 countries. The largest destination is TANZANIA accounting for 44.3% of APL Healthcare Limited's Tenofovir shipments, followed by MYANMAR (21.2%) and NIGERIA (11.6%). These destinations reflect APL Healthcare Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Tenofovir from APL Healthcare Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CHEMONICS INTERNATIONAL INC | TANZANIA | $550.0K | 11 |
| XXEMOXXCS XXTERXXTIOXXL IXX | TANZANIA | $550.0K | 11 |
| XXOPSXXYANXXR | MYANMAR | $400.0K | 8 |
| XXEMOXXCS XXTERXXTIOXXL IXX XXEMOXXCS XXTERXXTIO | TOGO | $300.0K | 6 |
| UNOPS MYANMAR NO 12 O | MYANMAR | $150.0K | 3 |
| XXSOLXXIONXX | NEPAL | $100.0K | 2 |
| XXROGXX SOXXH AXXICAXXPTYXXLIMITEDX | SOUTH AFRICA | $100.0K | 2 |
| CHEMONICS INTERNATIONAL INC CHEMONICS INTERNATIO | NIGERIA | $100.0K | 2 |
| I SOLUTIONS POLANERBAAN 11 | MOZAMBIQUE | $100.0K | 2 |
| XXSOLXXIONXX POXXNERXXAN XX | NIGERIA | $50.0K | 1 |
APL Healthcare Limited supplies Tenofovir to 14 buyers globally. The largest buyer is CHEMONICS INTERNATIONAL INC (TANZANIA), followed by XXEMOXXCS XXTERXXTIOXXL IXX (TANZANIA) and XXOPSXXYANXXR (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Tenofovir Export Value and How Much Does APL Healthcare Limited Contribute?
India exported $227.1M worth of Tenofovir through 7,518 shipments from 296 suppliers to 182 countries, serving 1,436 buyers globally. APL Healthcare Limited contributes $2.6M to this total, accounting for 0.1% of India's Tenofovir exports. APL Healthcare Limited ships Tenofovir to 10 countries through 14 buyers.
What Is the Average Shipment Value for APL Healthcare Limited's Tenofovir Exports?
APL Healthcare Limited's average Tenofovir shipment value is $50.0K per consignment, based on 53 shipments totaling $2.6M. The largest destination is TANZANIA (44.3% of APL Healthcare Limited's Tenofovir exports).
How Does APL Healthcare Limited Compare to Other Indian Tenofovir Exporters?
APL Healthcare Limited ranks #8 among 296 Indian Tenofovir exporters with a 0.1% market share. The top 3 exporters are HETERO LABS LIMITED ($64.3M), MYLAN LABORATORIES LIMITED ($50.1M), CIPLA LIMITED ($40.4M). APL Healthcare Limited processed 53 shipments to 10 destination countries.
What Tenofovir Formulations Does APL Healthcare Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR | $2.0M | 41 |
| DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR | $500.0K | 10 |
| EFAVIRENZ EMTRICITABINE AND TENOFOVIR | $44.3K | 2 |
APL Healthcare Limited exports 3 distinct Tenofovir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR with 41 shipments worth $2.0M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Tenofovir to Key Markets
What APL Healthcare Limited must comply with to export Tenofovir to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does APL Healthcare Limited Compare to Nearest Tenofovir Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | STRIDES PHARMA SCIENCE LIMITED | $3.8M | 75 | 21 | $50.0K |
| 12 | LUPIN LIMITED | $3.5M | 70 | 4 | $50.0K |
| 8 | APL HEALTHCARE LIMITED ★ | $2.6M | 53 | 10 | $50.0K |
| 9 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $2.1M | 43 | 15 | $50.0K |
| 11 | BHARAT PARENTERALS LIMITED | $1.4M | 28 | 1 | $50.0K |
APL Healthcare Limited ranks #8 among 296 Indian Tenofovir exporters. Average shipment value of $50.0K compared to the market average of $767.2K. The closest competitors by value are STRIDES PHARMA SCIENCE LIMITED and LUPIN LIMITED.
Which Indian Ports Ship Tenofovir Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,351 | 18.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,121 | 14.9% |
| NHAVA SHEVA SEA (INNSA1) | 526 | 7.0% |
| DELHI AIR CARGO ACC (INDEL4) | 463 | 6.2% |
| HYDERABAD AIR | 453 | 6.0% |
| DELHI AIR | 433 | 5.8% |
| Bombay Air | 371 | 4.9% |
| HYDERABAD ACC (INHYD4) | 351 | 4.7% |
What Other Antiviral & HIV Medications Products Does APL Healthcare Limited Export?
APL Healthcare Limited also exports these antiviral & hiv medications products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on APL Healthcare Limited's Tenofovir Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like APL Healthcare. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended transit times. These disruptions are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and inventory management. (pharmaceuticalcommerce.com)
Conversely, US-China trade tensions have prompted the United States to seek alternative pharmaceutical suppliers, potentially benefiting Indian exporters. However, the looming threat of US tariffs on pharmaceutical imports adds a layer of uncertainty. In March 2025, Indian pharma exports to the US surged by 74% amid tariff concerns, indicating proactive measures by exporters to mitigate potential impacts. (business-standard.com)
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on pharmaceuticals, enhancing market access for Indian exporters. This development offers APL Healthcare an opportunity to strengthen its presence in the European market, provided it aligns with EU regulatory standards. (en.wikipedia.org)
APL Healthcare Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India has made significant strides in this area, with 752 FDA-approved, 2,050 WHO GMP-certified, and 286 EDQM-approved manufacturing sites as of 2024. (business-standard.com) This robust compliance framework enhances the credibility of Indian pharmaceuticals in global markets.
For APL Healthcare, maintaining and enhancing compliance with FDA, WHO, and EU GMP standards is crucial. Adherence to evolving quality requirements not only ensures market access but also builds trust with international partners. Continuous investment in quality assurance and regulatory affairs will be essential to navigate the complex global pharmaceutical landscape.
About APL Healthcare Limited
APL Healthcare Limited exports 17 products worth $27.3M. Beyond Tenofovir, top products include Sertraline, Potassium, Fluoxetine, Dolutegravir, Losartan. View the complete APL Healthcare Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tenofovir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tenofovir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: APL Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 53 individual customs records matching APL Healthcare Limited exporting Tenofovir, covering 3 formulations to 10 countries via 14 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 182+ countries, 1,436+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tenofovir Export Data from APL Healthcare Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for APL Healthcare Limited's Tenofovir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
APL Healthcare Limited
Full Company Profile →
17 products · $27.3M total trade · 11 categories
Tenofovir Stats
Company Overview
Top Products by APL Healthcare Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for APL Healthcare Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tenofovir. For current shipment-level data, contact TransData Nexus.